Trulicity is a once-weekly injectable remedy used to enhance blood sugar management in adults with kind 2 diabetes. It’s a glucagon-like peptide-1 (GLP-1) receptor agonist, which suggests it really works by mimicking the consequences of a hormone referred to as GLP-1, which is launched by the intestine after consuming. GLP-1 helps to manage blood sugar ranges by slowing down the emptying of the abdomen, lowering urge for food, and growing insulin manufacturing.
Trulicity is efficient in decreasing blood sugar ranges and lowering the chance of cardiovascular occasions in individuals with kind 2 diabetes. It’s also well-tolerated, with the commonest unintended effects being gentle to reasonable gastrointestinal signs, equivalent to nausea, vomiting, and diarrhea. Trulicity isn’t advisable for individuals with kind 1 diabetes or diabetic ketoacidosis.
